Neogen Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Neogen Corporation (NEOG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $400.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-07-30
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2026 was $400.00K.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $0.00.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $73.00K, a 98.67% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|
| 2026-05-31 | $400.00K 10-K · filed 2026-07-30 | |
| 2025-05-31 | $0.00 10-K · filed 2026-07-30 | $46.00K 10-K · filed 2025-07-30 |
| 2024-05-31 | $0.00 10-K · filed 2026-07-30 | $37.00K 10-K · filed 2024-07-30 |
| 2023-05-31 | $73.00K 10-K · filed 2025-07-30 | |
| 2022-05-31 | $5.51M 10-K · filed 2024-07-30 | |
| 2021-05-31 | $22.35M 10-K · filed 2023-08-15 | |
| 2020-05-31 | $19.60M 10-K · filed 2022-07-27 | |
| 2019-05-31 | $21.38M 10-K · filed 2021-07-30 | |
| 2018-05-31 | $25.84M 10-K · filed 2020-07-30 | |
| 2017-05-31 | $18.07M 10-K · filed 2019-07-30 | |
| 2016-05-31 | $12.98M 10-K · filed 2018-07-27 | |
| 2015-05-31 | $10.69M 10-K · filed 2017-07-28 | |
| 2014-05-31 | $17.67M 10-K · filed 2016-07-29 | |
| 2013-05-31 | $12.52M 10-K · filed 2015-07-30 | |
| 2012-05-31 | $8.23M 10-K · filed 2014-07-30 | |
| 2011-05-31 | $15.26M 10-K · filed 2013-07-30 | |
| 2010-05-31 | $6.55M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |